Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Nephrol Dial Transplant. 2011 Nov;26(11):3451-7. doi: 10.1093/ndt/gfr448. Epub 2011 Aug 9.
Circulating immune complexes (CIC) containing galactose (Gal)-deficient IgA1 from adults with IgA nephropathy (IgAN) induce proliferation of cultured mesangial cells, but activities of CIC from pediatric patients with the disease have not been studied.
CIC of different sizes were isolated from sera of pediatric and adult IgAN patients and their effects on cultured human mesangial cells (MC) were assessed by measuring cellular proliferation, expression of IL-6 and IL-8 and laminin and phosphotyrosine signaling.
Large CIC from pediatric IgAN patients (>800 kDa) containing Gal-deficient IgA1 stimulated cellular proliferation, whereas in some patients, smaller CIC were inhibitory. Addition of stimulatory and inhibitory CIC to MC differentially altered phosphorylation patterns of three major tyrosine-phosphorylated proteins of molecular mass 37, 60 and 115 kDa. The stimulatory CIC transiently increased tyrosine-phosphorylation of the 37-kDa protein and decreased phosphorylation of the other two proteins, whereas the inhibitory CIC increased phosphorylation of all three proteins. Furthermore, we investigated the influence of IgA1-containing CIC from sera of children with IgAN with clinically active disease (i.e., abnormal urinalysis and/or serum creatinine concentration) or inactive disease (i.e., normal urinalysis and serum creatinine concentration) on the expression of IL-6 and IL-8 genes by mesangial cells. Real-time reverse transcription-polymerase chain reaction results showed that the CIC from a patient with active disease stimulated MC to express the two cytokine genes at higher levels than did the CIC from a patient with inactive disease. Moreover, stimulatory CIC increased production of the extracellular matrix protein laminin.
These data indicate that sera of pediatric IgAN patients contain biologically active CIC with Gal-deficient IgA1.
含有 IgA 肾病(IgAN)成人中缺乏半乳糖的循环免疫复合物(CIC)可诱导培养的系膜细胞增殖,但尚未研究来自小儿 IgAN 患者的 CIC 的活性。
从小儿和成人 IgAN 患者的血清中分离不同大小的 CIC,并通过测量细胞增殖、白细胞介素-6(IL-6)和白细胞介素-8(IL-8)以及层粘连蛋白和磷酸酪氨酸信号的表达来评估它们对培养的人系膜细胞(MC)的影响。
来自小儿 IgAN 患者(>800 kDa)的大 CIC 含有缺乏半乳糖的 IgA1,可刺激细胞增殖,而在一些患者中,较小的 CIC 具有抑制作用。刺激和抑制性 CIC 分别添加到 MC 中可改变三个主要酪氨酸磷酸化蛋白的磷酸化模式,其分子量分别为 37、60 和 115 kDa。刺激性 CIC 可短暂增加 37 kDa 蛋白的酪氨酸磷酸化,降低另外两种蛋白的磷酸化,而抑制性 CIC 则增加所有三种蛋白的磷酸化。此外,我们研究了来自患有 IgAN 且具有临床活动性疾病(即异常尿分析和/或血清肌酐浓度)或非活动性疾病(即正常尿分析和血清肌酐浓度)的儿童的 IgA1 含量的 CIC 对系膜细胞中 IL-6 和 IL-8 基因表达的影响。实时逆转录-聚合酶链反应结果表明,来自活动性疾病患者的 CIC 刺激 MC 以更高的水平表达两种细胞因子基因,而来自非活动性疾病患者的 CIC 则没有。此外,刺激性 CIC 增加了细胞外基质蛋白层粘连蛋白的产生。
这些数据表明,小儿 IgAN 患者的血清中含有具有半乳糖缺陷 IgA1 的生物活性 CIC。